Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ideaya Biosciences Inc (IDYA)

Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ideaya Biosciences Inc 5000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 USA

www.ideayabio.com Employees: 131 P: 650-443-6209

Sector:

Medical

Description:

IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences Inc. is based in South San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 3,141,950
Enterprise Value, $K 3,057,570
Shares Outstanding, K 87,666
Float, K 85,474
% Float 97.50%
Short Interest, K 8,247
Short Float 9.41%
Days to Cover 9.47
Short Volume Ratio 0.74
% of Insider Shareholders 2.50%
% of Institutional Shareholders 98.29%

Financials:

Annual Sales, $ 7,000 K
Annual Net Income, $ -274,480 K
Last Quarter Sales, $ 207,830 K
Last Quarter Net Income, $ 119,240 K
EBIT, $ -215,890 K
EBITDA, $ -235,290 K

Growth:

1-Year Return 61.18%
3-Year Return 103.29%
5-Year Return 94.78%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.33 on 11/04/25
Next Earnings Date 02/12/26 [--]
Earnings Per Share ttm -1.86
EPS Growth vs. Prev Qtr 251.14%
EPS Growth vs. Prev Year 321.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IDYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -15.55%
Return-on-Assets % -14.44%
Profit Margin % -3,921.14%
Debt/Equity 0.00
Price/Sales 14.71
Price/Cash Flow N/A
Price/Book 2.88
Book Value/Share 12.46
Interest Coverage -5.98
60-Month Beta 0.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar